Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS plays leading role in implementing curriculum for deaf learners
2013-08-15

 

Minister Angie Motshekga (front left) joined by members of the South African Sign Language task team. Behind Minister Motshekga’s shoulder is Dr Philemon Akach.
15 August 2013

South African Sign Language (SASL) will soon be offered as a school subject to Grade 0–12 learners in all 42 schools for the deaf in South Africa. Our Department of South African Sign Language had a role to play in this significant development that will empower deaf learners in South Africa and the continent.

Dr Philemon Akach, Head of the Department of South African Sign Language at the UFS, is part of the nine-member task team that recently handed over the SASL curriculum to the Minister of Basic Education, Angie Motshekga. The curriculum will be offered as a home language in all schools from 2014 and Grade 12 learners will be able to write it as a final-year examination subject.

Dr Akach – a member of the task team since 2009 – helped to coordinate the development of the curriculum.

The implementation of the curriculum means a lot to the Department of South African Sign Language, Dr Akach says. “We have championed the linguistic needs of the deaf community ever since we became the first university to offer SASL as an academic course, not only in South Africa, but also on the continent.”

Dr Akach says most Education students are already taking SASL as subject in his department, equipping them as prospective teachers to make implementation of the curriculum a smooth one. “Given our expertise, we will train teachers in the field and be involved in the setting and moderation of exam papers. The University of the Free State is no doubt a leader in this field.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept